In briefBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7362.460 (Published 31 August 2002) Cite this as: BMJ 2002;325:460
Infertility expert suspended: The head of the infertility clinic at the University Hospital of Wales, Lukas Klentzeris, has been suspended; the reason is unknown. He was not available for comment.
NICE proposes next treatment reviews: New treatments for lung cancer, motor neurone disease, and asthma are among those to be considered by the National Institute for Clinical Excellence for its next work programme. Comments on the proposed topics for consideration are invited by the end of September. See www.nice.org.uk for details.
UK to adopt tobacco advertising bill: Tobacco advertising is set to be banned in the United Kingdom by the end of the year as part of government's strategy to reduce the number of deaths from smoking related diseases. Research shows that such a ban could eventually save up to 3000 lives a year.
Manufacturers of diet supplements face legal action: The US Food and Drug Administration has prompted the Justice Department to open a criminal investigation into the manufacturer of Metabolife, a herbal stimulant and appetite suppressant containing ephedra, an amphetamine-like drug which has been linked to strokes, hypertension, heart attacks, and seizures. The FDA claims that the manufacturer knowingly suppressed reports of adverse side effects associated with the herbal diet pills.
New guidelines issued on withdrawing treatment: The United Kingdom's General Medical Council has issued guidance for doctors on withholding and withdrawing life prolonging treatment. The guidelines include when it might be appropriate for a doctor to discuss cardiopulmonary resuscitation with a patient. See www.gmc-uk.org
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial